Literature DB >> 10527765

Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal pericytes.

M Wakisaka1, M Yoshinari, S Nakamura, T Asano, K Sonoki, A h Shi, M Iwase, Y Takata, M Fujishima.   

Abstract

The effects of captopril on glucose uptake, as well as morphological and functional changes of retinal pericytes, in a high-glucose medium were examined. Retinal pericytes were incubated in medium with 5 and 30 mM glucose and 30 mM glucose with 10(-6) to 10(-3) M captopril. Captopril decreased the cellular uptakes of d-glucose and alpha-methyl glucoside in the presence, but not in the absence, of sodium. The cellular size and contents of glucose, sorbitol, and fructose were increased in 30 mM glucose concomitant with the decreased thymidine, cellular DNA content, and ratios in glucose to sorbitol and to fructose, compared with those in 5 mM glucose. These changes observed in 30 mM glucose were reversed by 10(-4) M captopril. These data suggest that the suppression of d-glucose uptake through a sodium-coupled glucose transporter by captopril may attenuate the swelling and loss of pericytes observed in the early stage of diabetic retinopathy. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527765     DOI: 10.1006/mvre.1999.2178

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  8 in total

Review 1.  Angiotensin II-related hypertension and eye diseases.

Authors:  Pablo Jesus Marin Garcia; Maria Encarna Marin-Castaño
Journal:  World J Cardiol       Date:  2014-09-26

Review 2.  Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.

Authors:  Sejal Lahoti; Mouhamed Nashawi; Omar Sheikh; David Massop; Mahnoor Mir; Robert Chilton
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-18

3.  Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors.

Authors:  Kinga Mikrut; Justyna Kupsz; Jacek Kozlik; Hanna Krauss; Ewa Pruszynska-Oszmałek; Magdalena Gibas-Dorna
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

4.  Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy.

Authors:  Masarori Wakisaka; Tetsuhiko Nagao
Journal:  Glycobiology       Date:  2017-08-01       Impact factor: 4.313

Review 5.  Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy.

Authors:  Lakshini Y Herat; Vance B Matthews; P Elizabeth Rakoczy; Revathy Carnagarin; Markus Schlaich
Journal:  Int J Endocrinol       Date:  2018-07-05       Impact factor: 3.257

Review 6.  Lessons from the Trials for the Desirable Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Diabetic Cardiovascular Events and Renal Dysfunction.

Authors:  Masanori Wakisaka; Masahiro Kamouchi; Takanari Kitazono
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

Review 7.  The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy.

Authors:  Wenjun Sha; Song Wen; Lin Chen; Bilin Xu; Tao Lei; Ligang Zhou
Journal:  J Diabetes Res       Date:  2020-11-12       Impact factor: 4.011

Review 8.  Roles of Sodium-Glucose Cotransporter 2 of Mesangial Cells in Diabetic Kidney Disease.

Authors:  Masanori Wakisaka; Kuniyuki Nakamura; Toshiaki Nakano; Takanari Kitazono
Journal:  J Endocr Soc       Date:  2021-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.